Literature DB >> 23979140

Regulated norepinephrine transporter interaction with the neurokinin-1 receptor establishes transporter subcellular localization.

Obulakshmi Arapulisamy1, Padmanabhan Mannangatti, Lankupalle D Jayanthi.   

Abstract

Neurokinin-1 receptor (NK1R) mediates down-regulation of human norepinephrine (NE) transporter (hNET) via protein kinase C (PKC). However, native NET regulation by NK1R and the mechanism by which NK1R targets NET among other potential effectors are unknown. Effect of NK1R activation on native NET regulation and NET/NK1R interaction were studied using rat brain synaptosomes expressing native NET and NK1R as well as human placental trophoblast (HTR) cells coexpressing WT-hNET or NK1R/PKC-resistant hNET-T258A,S259A double mutant (NET-DM) and hNK1R. The selective NK1R agonist, GR73632, and Substance-P (SP) inhibited NE transport and reduced plasma membrane expression of NET and NK1R. Pretreatment with the NK1R antagonist, EMEND (aprepitant) prevented these NK1R-mediated effects. Immunoprecipitation experiments showed that NET forms stable complexes with NK1R. In HTR cells, combined biotinylation and immunoprecipitation studies revealed plasma membrane localization of NET·NK1R complexes. Receptor activation resulted in the internalization of NET·NK1R complexes. Lipid raft and immunoprecipitation analyses revealed the presence of NET·NK1R complexes exclusively in non-raft membrane fractions under basal/unstimulated conditions. However, NK1R activation led to translocation of NET·NK1R complexes to raft-rich membrane fractions. Importantly, PKCα was found in association with raft-localized NET following SP treatment. Similar to WT-NET, PKC-resistant NET-DM was found in association with NK1R exclusively in non-raft fractions. However, SP treatment failed to translocate NET-DM·NK1R complexes from non-raft fractions to raft fractions. Collectively, these results suggest that NK1R forms physical complexes with NET and that the receptor-mediated Thr(258) + Ser(259) motif-dependent translocation of NET·NK1R complexes into raft-rich microdomains facilitates NET/NK1R interaction with PKCα to coordinate spatially restricted NET regulation.

Entities:  

Keywords:  Catecholamines; G Protein-coupled Receptors (GPCR); Internalization; Lipid Rafts; Monoamine Transporters; Plasma Membrane; Protein-protein Interactions; Regulation

Mesh:

Substances:

Year:  2013        PMID: 23979140      PMCID: PMC3789959          DOI: 10.1074/jbc.M113.472878

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  54 in total

1.  The gamma-aminobutyric acid receptor B, but not the metabotropic glutamate receptor type-1, associates with lipid rafts in the rat cerebellum.

Authors:  A Becher; J H White; R A McIlhinney
Journal:  J Neurochem       Date:  2001-11       Impact factor: 5.372

Review 2.  The solute carrier 6 family of transporters.

Authors:  Stefan Bröer; Ulrik Gether
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

3.  The NK1 receptor mediates both the hyperalgesia and the resistance to morphine in mice lacking noradrenaline.

Authors:  Luc Jasmin; Duc Tien; David Weinshenker; Richard D Palmiter; Paul G Green; Gabriella Janni; Peter T Ohara
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

4.  Dynamin and Rab5a-dependent trafficking and signaling of the neurokinin 1 receptor.

Authors:  F Schmidlin; O Dery; K O DeFea; L Slice; S Patierno; C Sternini; E F Grady; N W Bunnett
Journal:  J Biol Chem       Date:  2001-04-16       Impact factor: 5.157

5.  A regulated interaction of syntaxin 1A with the antidepressant-sensitive norepinephrine transporter establishes catecholamine clearance capacity.

Authors:  Uhna Sung; Subramaniam Apparsundaram; Aurelio Galli; Kristopher M Kahlig; Valentina Savchenko; Sally Schroeter; Michael W Quick; Randy D Blakely
Journal:  J Neurosci       Date:  2003-03-01       Impact factor: 6.167

6.  Protein phosphatase 2A mediates resensitization of the neurokinin 1 receptor.

Authors:  Jane E Murphy; Dirk Roosterman; Graeme S Cottrell; Benjamin E Padilla; Micha Feld; Eva Brand; Wendy J Cedron; Nigel W Bunnett; Martin Steinhoff
Journal:  Am J Physiol Cell Physiol       Date:  2011-07-27       Impact factor: 4.249

7.  Disruption of noradrenergic transmission and the behavioural response to a novel environment in NK1R-/- mice.

Authors:  Amy S Fisher; R John Stewart; Ting Yan; Stephen P Hunt; S Clare Stanford
Journal:  Eur J Neurosci       Date:  2007-02       Impact factor: 3.386

8.  Tyrosine phosphorylation of the human serotonin transporter: a role in the transporter stability and function.

Authors:  Balasubramaniam Annamalai; Padmanabhan Mannangatti; Obulakshmi Arapulisamy; Toni S Shippenberg; Lankupalle D Jayanthi; Sammanda Ramamoorthy
Journal:  Mol Pharmacol       Date:  2011-10-12       Impact factor: 4.436

9.  Dysregulation of dopamine transporter trafficking and function after abstinence from cocaine self-administration in rats: evidence for differential regulation in caudate putamen and nucleus accumbens.

Authors:  Devadoss J Samuvel; Lankupalle D Jayanthi; Senthilvelan Manohar; Kolanjiappan Kaliyaperumal; Ronald E See; Sammanda Ramamoorthy
Journal:  J Pharmacol Exp Ther       Date:  2008-01-15       Impact factor: 4.030

10.  Differential requirements for AP-2 in clathrin-mediated endocytosis.

Authors:  Sean D Conner; Sandra L Schmid
Journal:  J Cell Biol       Date:  2003-09-01       Impact factor: 10.539

View more
  10 in total

1.  Differential Internalization Rates and Postendocytic Sorting of the Norepinephrine and Dopamine Transporters Are Controlled by Structural Elements in the N Termini.

Authors:  Anne Vuorenpää; Trine N Jørgensen; Amy H Newman; Kenneth L Madsen; Mika Scheinin; Ulrik Gether
Journal:  J Biol Chem       Date:  2016-01-19       Impact factor: 5.157

2.  A Role for p38 Mitogen-activated Protein Kinase-mediated Threonine 30-dependent Norepinephrine Transporter Regulation in Cocaine Sensitization and Conditioned Place Preference.

Authors:  Padmanabhan Mannangatti; Kamalakkannan NarasimhaNaidu; Mohamad Imad Damaj; Sammanda Ramamoorthy; Lankupalle Damodara Jayanthi
Journal:  J Biol Chem       Date:  2015-02-27       Impact factor: 5.157

3.  Differential effects of aprepitant, a clinically used neurokinin-1 receptor antagonist on the expression of conditioned psychostimulant versus opioid reward.

Authors:  Padmanabhan Mannangatti; Santhanalakshmi Sundaramurthy; Sammanda Ramamoorthy; Lankupalle D Jayanthi
Journal:  Psychopharmacology (Berl)       Date:  2016-12-24       Impact factor: 4.530

Review 4.  Regulation of monoamine transporters and receptors by lipid microdomains: implications for depression.

Authors:  Joanne J Liu; Adrienne Hezghia; Saame Raza Shaikh; Joshua F Cenido; Ruth E Stark; J John Mann; M Elizabeth Sublette
Journal:  Neuropsychopharmacology       Date:  2018-06-28       Impact factor: 7.853

Review 5.  Kinase-dependent Regulation of Monoamine Neurotransmitter Transporters.

Authors:  Daniel P Bermingham; Randy D Blakely
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

6.  Blunted Amphetamine-induced Reinforcing Behaviors and Transporter Downregulation in Knock-in Mice Carrying Alanine Mutations at Threonine-258 and Serine-259 of Norepinephrine Transporter.

Authors:  Durairaj Ragu Varman; Padmanabhan Mannangatti; Mark A Subler; Jolene J Windle; Sammanda Ramamoorthy; Lankupalle D Jayanthi
Journal:  J Mol Neurosci       Date:  2022-07-19       Impact factor: 2.866

7.  Neurokinin-1 Antagonism Distinguishes the Role of Norepinephrine Transporter from Dopamine Transporter in Mediating Amphetamine Behaviors.

Authors:  Padmanabhan Mannangatti; Durairaj Ragu Varman; Sammanda Ramamoorthy; Lankupalle D Jayanthi
Journal:  Pharmacology       Date:  2021-09-02       Impact factor: 3.429

8.  Neuronal ablation of p-Akt at Ser473 leads to altered 5-HT1A/2A receptor function.

Authors:  Jeremy M Veenstra-Vanderweele; Aurelio Galli; Christine Saunders; Michael Siuta; Sabrina D Robertson; Adeola R Davis; Jennifer Sauer; Heinrich J G Matthies; Paul J Gresch; David Airey; Craig W Lindsley; John A Schetz; Kevin D Niswender
Journal:  Neurochem Int       Date:  2013-09-30       Impact factor: 3.921

9.  Salvinorin A regulates dopamine transporter function via a kappa opioid receptor and ERK1/2-dependent mechanism.

Authors:  Bronwyn Kivell; Zeljko Uzelac; Santhanalakshmi Sundaramurthy; Jeyaganesh Rajamanickam; Amy Ewald; Vladimir Chefer; Vanaja Jaligam; Elizabeth Bolan; Bridget Simonson; Balasubramaniam Annamalai; Padmanabhan Mannangatti; Thomas E Prisinzano; Ivone Gomes; Lakshmi A Devi; Lankupalle D Jayanthi; Harald H Sitte; Sammanda Ramamoorthy; Toni S Shippenberg
Journal:  Neuropharmacology       Date:  2014-08-10       Impact factor: 5.250

10.  Interference of norepinephrine transporter trafficking motif attenuates amphetamine-induced locomotor hyperactivity and conditioned place preference.

Authors:  Padmanabhan Mannangatti; Sammanda Ramamoorthy; Lankupalle Damodara Jayanthi
Journal:  Neuropharmacology       Date:  2017-10-04       Impact factor: 5.250

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.